Cargando…
A Phase I Clinical Trial of Systemically Delivered NEMO Binding Domain Peptide in Dogs with Spontaneous Activated B-Cell like Diffuse Large B-Cell Lymphoma
Activated B-Cell (ABC) Diffuse Large B-Cell Lymphoma (DLBCL) is a common, aggressive and poorly chemoresponsive subtype of DLBCL, characterized by constitutive canonical NF-κB signaling. Inhibition of NF-κB signaling leads to apoptosis of ABC-DLBCL cell lines, suggesting targeted disruption of this...
Autores principales: | Habineza Ndikuyeze, Georges, Gaurnier-Hausser, Anita, Patel, Reema, Baldwin, Albert S., May, Michael J., Flood, Patrick, Krick, Erika, Propert, Kathleen J., Mason, Nicola J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010398/ https://www.ncbi.nlm.nih.gov/pubmed/24798348 http://dx.doi.org/10.1371/journal.pone.0095404 |
Ejemplares similares
-
A recombinant HER2/neu expressing listeria monocytogenes (Lm-LLO) immunotherapy delays metastatic disease and prolongs overall survival in a spontaneous canine model of osteosarcoma - a Phase I clinical trial
por: Gnanandarajah, Josephine S, et al.
Publicado: (2014) -
NEMO surfaces in NF-κB–activating clusters
por: Leslie, Mitch
Publicado: (2014) -
Nemo
por: Domingo, Alain -
NEMO
por: Adya, Vaishali
Publicado: (2021) -
CD40-Activated B Cell Cancer Vaccine Improves Second Clinical Remission and Survival in Privately Owned Dogs with Non-Hodgkin's Lymphoma
por: Sorenmo, Karin U., et al.
Publicado: (2011)